Nitroglycerin topical - Kyowa Kirin International
Alternative Names: Anogesic; Cellegesic; Rectiv; RectogesicLatest Information Update: 27 Apr 2024
At a glance
- Originator Neptune Pharmaceuticals
- Developer Endo, Inc.; Epsilon Pharmaceuticals; Kyowa Kirin International; New Harbor Corporation
- Class Antineoplastics; Erectile dysfunction therapies; Heart failure therapies; Ischaemic heart disorder therapies; Nitro compounds; Organic nitrates; Small molecules; Sugar alcohols; Vasodilators
- Mechanism of Action Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Marketed Fissure in ano
- Discontinued Dyspareunia; Haemorrhoids; Pain; Vulvodynia
Most Recent Events
- 23 Apr 2024 Endo International has been acquired and merged into Endo, Inc.
- 24 Nov 2021 Adamas Pharmaceuticals has been acquired by Supernus Pharmaceuticals
- 18 Apr 2016 ProStrakan is now called Kyowa Kirin International